Our research project ‘Modulation of mitochondrial retrograde signaling as a treatment for Leigh syndrome’ has been selected by La Marató de TV3 Foundation, within its 2019 edition, dedicated to rare diseases, to receive 300,000 euros of funding.
It is a collaboration between Dr. Francesc Xavier Soriano’s lab and ours, in which we are going to study mitochondrial retrograde signaling (RTM), a mechanism neurons use to compensate for alterations produced by mitochondrial dysfunctions. Potentiating RTM through drugs as CBD is an interesting therapeutical approach for mitochondrial disease, but we still have to better understand how RTM works to find these drugs that can have the best effectiveness.
We are really glad to have this opportunity!